Go to the list of all blogs
AI dvisor's Avatar
published in Blogs
Nov 05, 2026
TickeronGET DAILY SIGNALS
Volaris (VLRS) Advances +14% on Record Q3 Revenue

Volaris (VLRS) Advances +14% on Record Q3 Revenue

Key Takeaways

  • VLRS advanced roughly 14% over the past 30 days, climbing from about $6.50 to the $7.41 area following a strong third-quarter earnings report.
  • Third-quarter revenue reached $1.04 billion, up 32% year over year, marking the first billion-dollar quarter in Volaris' history.
  • The U.S.–Mexico transborder business was the standout, with revenue up 53% year over year, while unit revenue (TRASM) rose 19%.
  • Despite a net loss of $26 million, results beat expectations, and management guided to stronger fourth-quarter unit revenue.
  • Shares remain down roughly 36% since the start of 2026, underscoring the depth of the earlier sell-off that preceded the recent rebound.

Understanding Volaris (VLRS) and Its Position in the Market

Volaris, the operating brand of Controladora Vuela Compañía de Aviación, S.A.B. de C.V., is a Mexican ultra-low-cost carrier serving Mexico, the United States, and Central and South America. The company operates a point-to-point model built on low base fares, with a fleet of roughly 154 Airbus aircraft — about 71% of which are fuel-efficient new-engine-option (NEO) models — and more than 247 routes. I follow VLRS closely as a proxy for Mexican and cross-border travel demand, particularly its growing U.S.–Mexico transborder corridor, which management has identified as its highest-return market. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

VLRS Stock Performance Over the Last 30 Days and Quarter

Over the last 30 days, VLRS has climbed approximately 14%, moving from a closing level near $6.50 to the $7.41 area. The move was concentrated in the final sessions of October and early November, when the company's third-quarter results triggered a sharp re-rating.

The broader quarterly picture is more volatile. Shares traded near $6.40 in early September, drifted lower through September and most of October, and touched a multi-month low near $5.60 in late October. The post-earnings rally then lifted the stock to its current level — roughly 16% above its early-September mark — while it remains well below its level at the start of 2026.

What Pushed VLRS Higher in Recent Weeks

The primary catalyst was Volaris' third-quarter 2026 earnings report, released on October 26. Revenue of $1.04 billion rose 32.4% year over year and topped consensus estimates, crossing the $1 billion mark for the first time. The net loss of $26 million, or $0.23 per ADS, was narrower than analysts had projected, and EBIT turned positive at $34 million.

Investors responded most strongly to the company's commercial momentum. TRASM increased 19.2% to 10.31 cents, driven by a 25.5% rise in average base fares to $55. Transborder revenue jumped 53% year over year, and management said international capacity would approach a record 49% of the total in the fourth quarter. A new $300 million revolving credit facility and progress on the Pratt & Whitney GTF engine recovery also reinforced the narrative of improving financial flexibility. From what I see, the transborder strength stands out as a key driver worth monitoring.

Factors Influencing VLRS Over the Past Quarter

Over the trailing quarter, VLRS was pressured by elevated fuel costs — average economic fuel cost rose 57% year over year to $4.10 per gallon — and by lingering fleet disruptions tied to GTF engine inspections. These headwinds contributed to the decline into late October and to the stock's roughly 36% year-to-date loss.

The quarterly trend reversed on improving fundamentals rather than any single external event. A U.S. Department of Transportation decision on October 16 to revoke earlier restrictions on Mexican carriers flying from the Mexico City metropolitan area removed a regulatory overhang, while the proposed airline group with Viva Aerobus, announced in late 2025, continued to draw investor attention. The decisive turn, however, came with third-quarter results, which showed disciplined capacity allocation toward higher-margin international routes paying off in unit revenue and margins. I’m watching this closely as capacity shifts continue.

Key Drivers for the VLRS Outlook Ahead

Looking ahead, investors are likely to focus on whether Volaris can sustain its unit-revenue momentum into the fourth quarter, when management has guided to roughly 4% ASM growth and approximately 17% year-over-year TRASM growth. Fuel prices, the U.S.–Mexico transborder environment, and the pace of GTF engine recovery remain key variables. The completion of the proposed airline group with Viva Aerobus, the company's ongoing fleet rightsizing toward about 137 aircraft by end-2027, and any developments in the FAA's assessment of Mexico's aviation oversight could also shape sentiment. Macroeconomic conditions in Mexico and the peso–dollar exchange rate will continue to influence both demand and cost structures.

Exploring Automated Strategies with Tickeron

In my own research process, I often turn to Tickeron’s AI Trading Bots to see how different automated approaches are positioned across sectors like airlines. These tools help filter strategies by performance and timeframe, offering a practical way to compare algorithmic views on market shifts without replacing manual analysis. One thing that stands out is how they can highlight trends in real time for stocks like VLRS.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: VLRS

Momentum Indicator for VLRS turns positive, indicating new upward trend

VLRS saw its Momentum Indicator move above the 0 level on October 27, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 84 similar instances where the indicator turned positive. In 70 of the 84 cases, the stock moved higher in the following days. The odds of a move higher are at 83%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for VLRS just turned positive on October 27, 2026. Looking at past instances where VLRS's MACD turned positive, the stock continued to rise in 34 of 43 cases over the following month. The odds of a continued upward trend are 79%.

VLRS moved above its 50-day moving average on November 02, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +8.47% 3-day Advance, the price is estimated to grow further. Considering data from situations where VLRS advanced for three days, in 245 of 314 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VLRS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.

VLRS broke above its upper Bollinger Band on October 30, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for VLRS entered a downward trend on October 30, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 12 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: VLRS's P/B Ratio (11.664) is very high in comparison to the industry average of (2.211). P/E Ratio (-4.312) is within average values for comparable stocks, (6.252). Projected Growth (PEG Ratio) (0.030) is also within normal values, averaging (2.252). VLRS has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.026). P/S Ratio (0.220) is also within normal values, averaging (0.529).

The Tickeron PE Growth Rating for this company is 33 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating steady price growth. VLRS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VLRS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock worse than average.

Notable companies

The most notable companies in this group are Delta Air Lines (NYSE:DAL), United Airlines Holdings (NASDAQ:UAL), Southwest Airlines Co (NYSE:LUV), American Airlines Group (NASDAQ:AAL), JetBlue Airways Corp (NASDAQ:JBLU).

Industry description

Airlines industry comprises passenger air transportation, including scheduled and non-scheduled routes. This can include charter airlines, as well as regular commuter ones. Discount pricing and the rise of low-cost carriers over recent decades have expanded the industry by making its services accessible to a much larger global population, compared to the older days when airline travel was a relative luxury for many people in the world. Delta Air Lines Inc., Southwest Airlines Co and United Continental Holdings, Inc. are some of the airlines with the largest stock market capitalizations in the U.S.

Market Cap

The average market capitalization across the Airlines Industry is 10.49B. The market cap for tickers in the group ranges from 384.9K to 1.51T. AZULD holds the highest valuation in this group at 1.51T. The lowest valued company is AIBEF at 384.9K.

High and low price notable news

The average weekly price growth across all stocks in the Airlines Industry was 9%. For the same Industry, the average monthly price growth was 0%, and the average quarterly price growth was -6%. AZUL experienced the highest price growth at 29%, while FLYX experienced the biggest fall at -17%.

Volume

The average weekly volume growth across all stocks in the Airlines Industry was 24%. For the same stocks of the Industry, the average monthly volume growth was 51% and the average quarterly volume growth was 6%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 40
P/E Growth Rating: 46
Price Growth Rating: 58
SMR Rating: 66
Profit Risk Rating: 72
Seasonality Score: 7 (-100 ... +100)
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a provider of air transportation services

Industry Airlines

Industry
Airlines
Address
Avenue Antonio Dovali Jaime No. 70
Phone
+52 5552616400
Employees
7098
Web
https://www.volaris.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
RBLX shares plunged approximately 24% in premarket trading on Friday, May 1, 2026, falling roughly $13.36 to around $41.90 from the prior close of approximately $55.26. The primary catalyst was a dramatic cut to full-year 2026 bookings guidance, slashed to $7.33B–$7.60B from $8.28B–$8.55B.
SMMT shares fell approximately 20% in premarket trading on Friday, May 1, 2026, dropping from a prior close of approximately $20.83 to around $16.66. The primary catalyst was the HARMONi-3 interim PFS analysis miss, with the Phase III global trial failing to meet expectations for its squamous cohort, undermining the ivonescimab thesis.